Clinical protection against caprine herpesvirus 1 genital infection by intranasal administration of a live attenuated glycoprotein e negative bovine herpesvirus 1 vaccine

BMC Veterinary Research

Volumn 3, Issue , 2007, Pages

  Thiry, Julien ^a,b   Tempesta, Maria ^a   Camero, Michele ^a   Tarsitano, Elvira ^a   Muylkens, Benoît ^b   Meurens, François ^c   Thiry, Etienne ^b   Buonavoglia, Canio ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UR1282   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE HERPESVIRUS 1; CAPRA HIRCUS; CAPRINE HERPESVIRUS 1; HUMAN HERPESVIRUS 1;

GLYCOPROTEIN E, BOVINE HERPESVIRUS TYPE 1; HERPES VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; BLOOD; BODY TEMPERATURE; CATTLE; CELL LINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; FEMALE; GOAT; GOAT DISEASE; GYNECOLOGIC DISEASE; HERPES VIRUS INFECTION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; VARICELLA ZOSTER VIRUS; VIROLOGY; VIRUS SHEDDING;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BODY TEMPERATURE; CATTLE; CELL LINE; CROSS REACTIONS; FEMALE; GENITAL DISEASES, FEMALE; GOAT DISEASES; GOATS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS VACCINES; VACCINES, ATTENUATED; VARICELLOVIRUS; VIRAL ENVELOPE PROTEINS; VIRUS SHEDDING;

EID: 39049159217     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-3-33     Document Type: Article

References (54)

1. Thiry J, Keuser V, Muylkens B, Meurens F, Gogev S, Vanderplasschen A, Thiry E: Ruminant alphaherpesviruses related to bovine herpesvirus 1. Vet Res 2006, 37:169-190.
2. Muylkens B, Thiry J, Kirten P, Schynts F, Thiry E: Bovine herpesvirus 1 and infectious bovine rhinotracheitis. Vet Res 2007, 38:181-209.
3. van Oirschot JT, Kaashoek MJ, Rijsewijk FA: Advances in the development and evaluation of bovine herpesvirus 1 vaccines. Vet Microbiol 1996, 53:43-54.
4. Mars MH, De Jong MC, van Oirschot JT: A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments. Vaccine 2000, 18:1975-1981.
5. Mars MH, De Jong MC, Franken P, van Oirschot JT: Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field. Vaccine 2001, 19:1924-1930.
6. Saito JK, Gribble DH, Berrios PE, Knight HD, Mc Kercher DG: A new herpesvirus isolate from goats: Preliminary report. Am J Vet Res 1974, 35:847-848.
7. Van der Lugt JJ, Randles JL: Systemic herpesvirus infection in neonatal goats. J S Afr Vet Assoc 1993, 64:169-171.
8. Tarigan S, Webb RF, Kirkland D: Caprine herpesvirus from balanoposthitis. Aust Vet J 1987, 64:321.
9. Grewal AS, Wells R: Vulvovaginitis of goats due to a herpesvirus. Aust Vet J 1986, 63:79-82.
10. Keuser V, Gogev S, Schynts F, Thiry E: Demonstration of generalized infection with caprine herpesvirus 1 diagnosed in an aborted caprine foetus by PCR. Vet Res Commun 2002, 26:221-226.
11. Tempesta M, Buonavoglia D, Sagazio P, Pratelli A, Buonavoglia C: Natural reactivation of caprine herpesvirus 1 in latently infected goats. Vet Rec 1998, 143:200.
12. Tempesta M, Pratelli A, Corrente M, Buonavoglia C: A preliminary study on the pathogenicity of a strain of caprine herpesvirus-1. Comp Immunol Microbiol Infect Dis 1999, 22:137-143.
13. Tempesta M, Pratelli A, Greco G, Martella V, Buonavoglia C: Detection of caprine herpesvirus 1 in sacral ganglia of latently infected goats by PCR. J Clin Microbiol 1999, 37:1598-1599.
14. Guercio A, Greco G, Lanizzoto G, Di Marco V, Todaro M: Valutazione della diffusione di anticorpi anti Herpes Virus della capra in allevamenti caprini della Sicilia. Atti SIPAOC 1998, 12:138-142.
15. Kao M, Leiskau T, Koptopoulos G, Papadopoulos O, Horner GW, Hyllseth B, et al.: Goat herpesvirus infections: a survey on specific antibodies in different countries. In Immunity to herpesvirus infections of domestic animals Edited by: Pastoret P-P, Thiry E, Saliki JT. Luxembourg: Report EUR 9737 EN; 1985:93-97.
16. Keuser V, Espejo-Serrano J, Schynts F, Georgin JP, Thiry E: Isolation of caprine herpesvirus type 1 in Spain. Vet Rec 2004, 154:395-399.
17. Koptopoulos G, Papanastasopoulou M, Papadopoulos O, Ludwig H: The epizootiology of caprine herpesvirus (BHV-6) infections in goat populations in Greece. Comp Immunol Microbiol Infect Dis 1988, 11:199-205.
18. Muluneh A, Liebermann H: Occurrence of caprine herpesvirus (BHV-6) infection in goat population of the GDR. Arch Exp Veterinarmed 1990, 44(2):254-257.
19. Plebani GF, Engels M, Metzler AE, Wyler R: Caprines Herpesvirus in der Schweiz: Verbreitung Haüfigkeit und Latenz der Infektion. Schweiz Arch Tierheilkd 1983, 125:395-411.
20. Thiry J, Keuser V, Schynts F, Chartier C, Tempesta M, Espejo-Serrano J, Saegerman C, Thiry E: Evaluation de la prévalence sérologique de l'infection par l'herpèsvirus caprin 1 dans le sud-ouest de l'Europe. Epidémiol Santé Anim 2006, 49:55-8.
21. Tempesta M, Camero M, Greco G, Pratelli A, Martella V, Buonavoglia C: A classical inactivated vaccine induces protection against caprine herpesvirus 1 infection in goats. Vaccine 2001, 19:3860-3864.
22. Camero M, Bellacicco AL, Tarsitano E, Decaro N, Martella V, Tempesta M, Buonavoglia C: Intravaginal administration of an inactivated vaccine prevents lesions induced by caprine herpesvirus-1 in goats. Vaccine 2007, 25:1658-1661.
23. Berrios PE, McKercher DG, Knight HD: Pathogenicity of a caprine herpesvirus. Am J Vet Res 1975, 36:1763-1769.
24. Mettler F, Engels M, Wild P, Bivetti A: Herpesvirus-Infektion bei Zicklein in der. Schweiz Arch Tierheilkd 1979, 121:655-662.
25. Ackermann M, Metzler AE, McDonaugh H, Bruckner L, Muller HK, Kihm U: Stellen nichtbovine paarhufer ein IBR-Virus-reservoir dar? I. BHV-1 und CapHV-1 infektions und reaktivierungsversuche an ziegen, virustyp-spezifitat der humoralen antikorper und charakterisierung der viralen antigene. Schweiz Arch Tierheilkd 1986, 128:557-573.
26. Ros C, Belak S: Studies of genetic relationships between bovine, caprine, cervine, and rangiferine alphaherpesviruses and improved molecular methods for virus detection and identification. J Clin Microbiol 1999, 37:1247-1253.
27. Ros C, Belak S: Characterization of the glycoprotein B gene from ruminant alphaherpesviruses. Virus Genes 2002, 24:99-105.
28. Ros C, Riquelme ME, Forslund KO, Belak S: Improved detection of five closely related ruminant alphaherpesviruses by specific amplification of viral genomic sequences. J Virol Methods 1999, 83:55-65.
29. Pirak M, Thiry E, Brochier B, Pastoret P-P: Infection expérimentale de la chèvre par le virus de la rhinotraché ite infectieuse bovine (bovine herpes virus 1) et tentative de réactivation virale. Rec Méd Vét 1983, 159:1103-1106.
30. Engels M, Palatini M, Metzler AE, Probst U, Kihm U, Ackermann M: Interactions of bovine and caprine herpesviruses with the natural and the foreign hosts. Vet Microbiol 1992, 33:69-78.
31. Six A, Banks M, Engels M, Bascunana CR, Ackermann M: Latency and reactivation of bovine herpesvirus 1 (BHV-1) in goats and of caprine herpesvirus 1 (CapHV-1) in calves. Arch Virol 2001, 146:1325-1335.
32. Thiry J, Tempesta M, Camero M, Tarsitano E, Bellacicco AL, Thiry E, Buonavoglia C: A live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine induces a partial cross-protection against caprine herpesvirus 1 infection in goats. Vet Microbiol 2006, 113:303-308.
33. Davis SS: Nasal vaccines. Adv Drug Deliv Rev 2001, 51:21-42.
34. Bergquist C, Johansson EL, Lagergard T, Holmgren J, Rudin A: Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997, 65:2676-2684.
35. Johansson EL, Wassen L, Holmgren J, Jertborn M, Rudin A: Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001, 69:7481-7486.
36. Brandtzaeg P, Baekkevold ES, Farstad IN, Jahnsen FL, Johansen FE, Nilsen EM, Yamanaka T: Regional specialization in the mucosal immune system: what happens in the microcompartments? Immunol Today 1999, 20:141-151.
37. Eriksson K, Quiding-Jarbrink M, Osek J, Moller A, Bjork S, Holmgren J, Czerkinsky C: Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination. Infect Immun 1998, 66:5889-5896.
38. Johansson EL, Rask C, Fredriksson M, Eriksson K, Czerkinsky C, Holmgren J: Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun 1998, 66:514-520.
39. Perry LL, Feilzer K, Portis JL, Caldwell HD: Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice. J Immunol 1998, 160:2905-2914.
40. Johansson EL, Rudin A, Wassen L, Holmgren J: Distribution of lymphocytes and adhesion molecules in human cervix and vagina. Immunology 1999, 96:272-277.
41. Johansen FE, Baekkevold ES, Carlsen HS, Farstad IN, Soler D, Brandtzaeg P: Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. Blood 2005, 106:593-600.
42. Meurens F, Whale J, Brownlie R, Dybvig T, Thompson DR, Gerdts V: Expression of mucosal chemokines TECK/CCL25 and MEC /CCL28 during fetal development of the ovine mucosal immune system. Immunology 2007, 120:544-555.
43. Lemaire M, Schynts F, Meyer G, Georgin JP, Baranowski E, Gabriel A, Ros C, Belak S, Thiry E: Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies. Vaccine 2001, 19:4795-4804.
44. Thiry E, Meurens F, Muylkens B, McVoy M, Gogev S, Thiry J, Vanderplasschen A, Schynts F: Recombination in alphaherpesviruses. Rev Med Virol 2005, 15:89-103.
45. Pagamjav O, Sakata T, Matsumura T, Yamaguchi T, Fukushi H: Natural recombinant between equine herpesviruses 1 and 4 in the ICP4 gene. Microbiol Immunol 2005, 49:167-179.
46. Meurens F, Keil GM, Muylkens B, Gogev S, Schynts F, Negro S, Wiggers L, Thiry E: Interspecific recombination between two ruminant alphaherpesviruses, bovine herpesviruses 1 and 5. J Virol 2004, 78:9828-9836.
47. Tempesta M, Pratelli A, Normanno G, Camero M, Buonavoglia D, Greco G, Buonavoglia C: Experimental intravaginal infection of goats with caprine herpesvirus 1. J Vet Med B Infect Dis Vet Public Health 2000, 47:197-201.
48. Tempesta M, Greco G, Pratelli A, Buonavoglia D, Camero M, Martella V, Buonavoglia C: Reactivation of caprine herpesvirus 1 in experimentally infected goats. Vet Rec 2002, 150:116-117.
49. Howell DC: Power considerations in terms of sample size. Statistical Methods for Psychology. Duxbury Fourth edition. 1997:226.
50. Committee for Veterinary Medicinal Products: Position paper regarding availability of products for minor uses and minor species (MUMS). European Medicine Agency. Luxembourg:EMEA /CVMP/477/03/final; 2004:1-13.
51. Buonavoglia C, Tempesta M, Cavalli A, Voigt V, Buonavoglia D, Conserva A, Corrente M: Reactivation of caprine herpesvirus 1 in latently infected goats. Comp Immunol Microbiol Infect Dis 1996, 19:275-281.
52. Miller JM, van der Maaten MJ: Reproductive tract lesions in heifers after intrauterine inoculation with infectious bovine rhinotracheitis virus. Am J Vet Res 1984, 45:790-794.
53. Vilcek S: Detection of the bovine herpesvirus-1 (BHV-1) genome by PCR. J Virol Methods 1993, 41:245-247.
54. Littell RC, Henry PR, Ammerman CB: Statistical analysis of repeated measures data using SAS procedures. J Anim Sci 1998, 76:1216-1231.